Stifel analyst Rick Wise raised the firm’s price target on Intuitive Surgical to $430 from $420 and keeps a Buy rating on the shares after having hosted an investor dinner with two high-volume, robotic focused general surgeons. Both physicians were impressed with dV5 and are “eager to adopt” dV5 and expect their hospital system to rapidly upgrade their 25-30 system dV Xi fleet, says the analyst, who adds that neither are yet viewing the system as a “gamechanger” versus the da Vinci Xi.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $462 from $428 at Citi
- Paging Dr. Nvidia (NASDAQ:NVDA): AI and Healthcare
- UFP Technologies announces $500M amended supply agreement with Intuitive Surgical
- China stimulus positive for GE HealthCare, tool companies, says Evercore ISI
- Intuitive (NASDAQ:ISRG) Gets FDA’s Nod for Next-Gen Robotic System
